Vericel Corporation
Vericel Corporation, a leading player in the regenerative medicine industry, is headquartered in the United States. Founded in 1989, the company has made significant strides in developing innovative cell-based therapies, particularly for patients with severe skin injuries and cartilage damage. Vericel's core products, including Epicel® and MACI®, are distinguished by their ability to harness the body’s own cells to promote healing, setting them apart in the competitive landscape of advanced therapeutics. With a strong presence in the US and expanding operations in key international markets, Vericel has established itself as a pioneer in the field. The company’s commitment to research and development has led to notable achievements, including FDA approvals that underscore its market position. Vericel continues to drive advancements in regenerative medicine, aiming to improve patient outcomes and redefine treatment paradigms.
DitchCarbon Score
How does Vericel Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Vericel Corporation's score of 35 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Vericel Corporation's reported carbon emissions
In 2023, Vericel Corporation reported total carbon emissions of approximately 261,005,020 kg CO2e. This figure includes 188,887,860 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources. Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling, amounted to about 972,310 kg CO2e. Additionally, Scope 3 emissions, which encompass all other indirect emissions, totalled approximately 71,144,850 kg CO2e, with significant contributions from upstream transportation and distribution (about 18,133,000 kg CO2e) and downstream transportation and distribution (approximately 30,309,000 kg CO2e). In comparison, the 2022 emissions data indicated a total of about 194,012,610 kg CO2e, with Scope 1 emissions at 146,646,730 kg CO2e and Scope 2 emissions at approximately 13,649,310 kg CO2e. Scope 3 emissions for that year were around 33,716,570 kg CO2e. Despite these figures, Vericel Corporation has not publicly committed to specific reduction targets or initiatives, nor do they have any climate pledges documented. The absence of reduction targets suggests a need for further commitment to climate action within the industry context. The emissions data is not cascaded from any parent company, indicating that it is independently reported by Vericel Corporation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 146,646,730 | 000,000,000 |
| Scope 2 | 13,649,310 | 000,000 |
| Scope 3 | 33,716,570 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Vericel Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
